Scientific Advisors
Carolyn R. Bertozzi, PhD - Founder and Chair, Scientific Advisory Board
Professor Bertozzi is the T.Z. and Irmgard Chu Distinguished Professor of Chemistry and Professor of Molecular and Cell Biology at UC Berkeley and an Investigator of the Howard Hughes Medical Institute. She previously served as the Director of the Molecular Foundry, a nanoscience institute at the Lawrence Berkeley National Laboratory. Professor Bertozzi’s research interests span the disciplines of chemistry and biology with an emphasis on studies of cell surface glycosylation pertinent to disease states. Her lab focuses on profiling changes in cell surface glycosylation associated with cancer, inflammation and bacterial infection, and exploiting this information for development of diagnostic and therapeutic approaches. In addition, her group develops nanoscience-based technologies for probing cell function and for medical diagnostics. The Redwood technology platform was developed with her research group at UC Berkeley.
Professor Bertozzi is a member of the National Academy of Sciences and the American Academy of Arts and Sciences. She has been recognized with the Ernst Schering Prize, the MacArthur Foundation Fellowship, the ACS Award in Pure Chemistry, the Presidential Early Career Award in Science and Engineering, and the Irving Sigal Young Investigator Award of the Protein Society, among many others. Her efforts in undergraduate education have earned her the UC Berkeley Distinguished Teaching Award and the Donald Sterling Noyce Prize for Excellence in Undergraduate Teaching. Professor Bertozzi received her undergraduate degree in Chemistry from Harvard University, her Ph.D. in Chemistry from UC Berkeley and completed her postdoctoral work at UC San Francisco (“UCSF”) in the field of cellular immunology.
Tom Muir, PhD - Member, Scientific Advisory Board
Professor Muir is the Van Zandt Williams Class of 1965 Professor of Chemistry at Princeton University. Previously he was the Richard E. Salomon Family Professor and Director of the Pels Center of Chemistry, Biochemistry and Structural Biology at the Rockefeller University. He is one of the world’s leading experts in protein chemistry for bioconjugation. Professor Muir has published over 100 scientific articles and has won a number of honors for his research, including: the Burroughs-Wellcome Fund New Investigator Award, the Pew Award in the Biomedical Sciences, the Alfred P. Sloan Research Fellow Award, the Leonidas Zervas Award from the European Peptide Society, the Irving Sigal Young Investigator Award from the Protein Society, the 2008 Vincent du Vigneaud Award in Peptide Chemistry, the 2008 Blavatnik Award from the New York Academy of Sciences and the 2008 Distinguished Teaching Award from The Rockefeller University. Professor Muir is a Kavli Fellow of the US National Academy of Sciences and a Fellow of American Association for the Advancement of Science. He received his B.Sc (Hons, 1st class) in Chemistry from the University of Edinburgh and his Ph.D. in Chemistry from the same institute. Professor Muir completed his postdoctoral studies with Stephen B.H. Kent at the Scripps Research Institute.
Ted Yednock, PhD - Member, Scientific Advisory Board
Dr. Yednock is an Executive Vice President and the Head of Global Research for Elan Pharmaceuticals. He joined Elan with its acquisition of Athena Neurosciences. During Dr. Yednock's tenure at Athena, he initiated research on multiple sclerosis which led to the development of Tysabri, a marketed monoclonal antibody with 2009 sales of over $1 billion. Dr. Yednock has contributed to the invention or progression of more than a dozen drugs in the areas of rheumatoid arthritis, Crohn's disease, pain and Alzheimer's disease, in addition to his work in multiple sclerosis. His Research team has filed 8 INDs in the past 5 years covering drugs currently in Phase I to Phase III trials. Dr. Yednock has been involved in collaborations with Biogen-Idec, Wyeth/Genetics Institute, Johnson & Johnson, the Michael J. Fox foundation, the Alzheimer's Drug Discovery foundation and the Parkinson's Institute, among others. He earned his B.S. in Biology and Chemistry from the University of Illinois and his Ph.D. in Anatomy and Cell Biology from UCSF. Dr. Yednock completed postdoctoral fellowships in Anatomy and Cell Biology and Immunology/Microbiology at the same institution.
Redwood also has retained several consultants who are leading drug discovery and development experts in the areas of antibody-drug conjugates, peptide therapeutics, oncology and manufacturing.